Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Adds Black Box Warning to Ocaliva

The liver disease medicine Ocaliva was erroneously dosed daily rather than weekly, putting patients at risk of serious liver injury.

Ocaliva / Image: Intercept
Ocaliva / Image: Intercept

A recent FDA MedWatch article noted that the FDA is adding a black box warning to Ocaliva, the only product marketed by Intercept Pharmaceuticals. The drug was incorrectly dosed daily instead of weekly for patients with a rare chronic liver disease. To prevent risk of liver problems, the FDA is clarifying recommendations for the drug with a Boxed Warning.

In the warning, the FDA highlights the heightened risk of liver decompensation or failure if improper dosage is taken. The warning doesn’t ask physicians to limit use of the drug in patients with the disease, but rather to closely monitor patients to watch for declining liver function or progressing cirrhosis.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences